Pharmaceutical care: pharmacy involvement in prescribing in an acute-care hospital.

作者: Consol Galindo , Montse Olivé , Carmen Lacasa , Julio Martínez , Cristina Roure

DOI: 10.1023/A:1023201115649

关键词:

摘要: Background: Pharmaceutical care implies reaching a consensus with physicians on prescriptions in cases that call for the substitution of one active ingredient another, modification dose, frequency, route administration, etc., through unit‐dose distribution system. The goal pharmacist interventions hospital should be to achieve rational use drugs; ensure this, daily review patient by is necessary. Most incidence drug‐related morbidity and mortality predictable can avoided, thus reducing overall cost health duration hospitalization while improving quality care. optimum physician or achieved would which maximizes benefits minimizes risks costs.Objective: this study was evaluate at Hospital Barcelona over six‐month period their clinical economic repercussions degree compliance. Method: were recorded card classified type: antibiotic thromboembolic prophylaxis; an principle not included hospital's Pharmacotherapeutic Guide; change dose administration; therapeutic duplication; adjustment aminoglycosides vancomycin; inappropriate treatment duration. evaluation considered average stay procedures diagnostics 1998 applied data published probability rates drug costs.Results: A total 3,136 analyzed prospectively during period. represented savings 129,058.31 euros. Those contributed most these recommendations prophylaxis, prophylaxis pharmacokinetics studies: 49.4, 47 5.7% interventions, respectively, 79, 3.6 15% savings, respectively. Conclusion: In general, acceptance high (88.8%), as result growing compliance established protocols. It concluded have been useful improve important help educate therapy.

参考文章(16)
P. M. L. A. van den Bemt, A. C. G. Egberts, A. W. Lenderink, J. M. Verzijl, K. A. Simons, W. S. C. J. M. van der Pol, H. G. M. Leufkens, Adverse drug events in hospitalized patients: A comparison of doctors, nurses and patients as sources of reports European Journal of Clinical Pharmacology. ,vol. 55, pp. 155- 158 ,(1999) , 10.1007/S002280050611
JA Rubio-Manzanares Bermejo, JE Baeza Berruti, MC Palacios López, JA Martínez Escudero, Impacto de un programa de uso racional del medicamento sobre la prescripción farmacéutica en un área de salud Atencion Primaria. ,vol. 18, pp. 551- 557 ,(1996)
Jacqueline D. Pilzer, Timothy G. Burke, Alan H. Mutnick, Drug allergy assessment at a university hospital and clinic American Journal of Health-system Pharmacy. ,vol. 53, pp. 2970- 2975 ,(1996) , 10.1093/AJHP/53.24.2970
J L Ibáñez Pardos, J Jiménez Villa, D Crusat Sabaté, M T Pérez Rodríguez, Impacto de un proceso de feed-back informativo sobre la prescripción farmacéutica Atencion Primaria. ,vol. 18, pp. 386- 389 ,(1996)
Philip W. Keys, Carla M. Goetz, Patricia A. Keys, James A. Sterchele, Thomas M. Snedden, Bruce H. Livengood, Computer-guided academic detailing as part of a drug benefit program. American Journal of Health-system Pharmacy. ,vol. 52, pp. 2199- 2204 ,(1995) , 10.1093/AJHP/52.20.2199
Alan H. Mutnick, Kenneth J. Sterba, Julie A. Peroutka, Nancy E. Sloan, Elizabeth A. Beltz, Mark K. Sorenson, Cost savings and avoidance from clinical interventions American Journal of Health-system Pharmacy. ,vol. 54, pp. 392- 396 ,(1997) , 10.1093/AJHP/54.4.392
JOHN M. EISENBERG, What is the Cost of Nephrotoxicity Associated with Aminoglycosides Annals of Internal Medicine. ,vol. 107, pp. 900- 909 ,(1987) , 10.7326/0003-4819-107-6-900
David Bergqvist, Screening and Diagnosis of Deep Vein Thrombosis and Pulmonary Embolism Haemostasis. ,vol. 23, pp. 57- 60 ,(1993) , 10.1159/000216910
Philip J. Schneider, Maja G. Gift, Yu-Ping Lee, Elizabeth A. Rothermich, Bruce E. Sill, Cost of medication-related problems at a university hospital. American Journal of Health-system Pharmacy. ,vol. 52, pp. 2415- 2418 ,(1995) , 10.1093/AJHP/52.21.2415
Charles D. Hepler, Linda M. Strand, Opportunities and responsibilities in pharmaceutical care. American Journal of Health-system Pharmacy. ,vol. 47, pp. 533- 543 ,(1990) , 10.1093/AJHP/47.3.533